In this week's episode we are excited to welcome Ole Mensching, Ph. D., Co-Founder and General Partner at Apollo Health Ventures.

Apollo Health Ventures is a transatlantic early-stage Venture Capital firm specialising in co-founding and investing in healthcare companies targeting age-related diseases. They actively participate in founding ventures, alongside investing in best-in-class external opportunities.

This discussion explores the synergy between science and venture capital, emphasising the role of artificial intelligence in longevity. Apollo Health Ventures' distinct investment approach, combining active co-founding and external opportunities, is highlighted. Key factors like investment periods and ticket size are discussed for their impact on venture success, considering the delicate balance between risk and returns in longevity investing. The conversation concludes with an outlook on the future of longevity and the venture capital market, providing insights into the evolving landscape of healthcare innovation and investment.